Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
13.61
-0.70 (-4.89%)
At close: Nov 13, 2026, 4:00 PM EST
13.68
+0.07 (0.51%)
After-hours: Nov 13, 2026, 7:30 PM EST
Korro Bio Market Cap
Korro Bio has a market cap or net worth of $186.81 million as of November 13, 2026. It is the 20,866th most valuable company in the world and the 3,568th biggest in the United States. Its market cap has decreased by 36.87% in one year.
Market Cap
186.81M
Enterprise Value
103.51M
1-Year Change
-36.87%
Global Rank
Country Rank
#3,568 United States
Category
ChartMarket Cap Chart
Since November 6, 2023, Korro Bio's market cap has increased from $123.80M to $186.81M, an increase of 50.90%. That is a compound annual growth rate of 14.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 186.81M | 147.65% |
| Dec 31, 2025 | 75.43M | -78.85% |
| Dec 31, 2024 | 356.65M | -6.96% |
| Dec 29, 2023 | 383.31M | 209.63% |
| Nov 6, 2023 | 123.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Palisade Bio | 204.38M |
| Eledon Pharmaceuticals | 201.73M |
| Compugen | 200.82M |
| Keros Therapeutics | 197.81M |
| ProQR Therapeutics | 197.57M |
| Artiva Biotherapeutics | 195.75M |
| Pyxis Oncology | 193.76M |
| Cartesian Therapeutics | 193.69M |